486 related articles for article (PubMed ID: 27903991)
1. Role of Oxidative Stress and Inflammatory Factors in Diabetic Kidney Disease.
Aghadavod E; Khodadadi S; Baradaran A; Nasri P; Bahmani M; Rafieian-Kopaei M
Iran J Kidney Dis; 2016 Nov; 10(6):337-343. PubMed ID: 27903991
[TBL] [Abstract][Full Text] [Related]
2. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
Elmarakby AA; Sullivan JC
Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy.
Sun YM; Su Y; Li J; Wang LF
Biochem Biophys Res Commun; 2013 Apr; 433(4):359-61. PubMed ID: 23541575
[TBL] [Abstract][Full Text] [Related]
4. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory Effects of the Nutraceutical Garlic Derivative Allicin in the Progression of Diabetic Nephropathy.
Arellano Buendía AS; Tostado González M; Sánchez Reyes O; García Arroyo FE; Argüello García R; Tapia E; Sánchez Lozada LG; Osorio Alonso H
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314265
[TBL] [Abstract][Full Text] [Related]
6. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
Chilelli NC; Burlina S; Lapolla A
Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
[TBL] [Abstract][Full Text] [Related]
7. Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease.
Miranda-Díaz AG; Pazarín-Villaseñor L; Yanowsky-Escatell FG; Andrade-Sierra J
J Diabetes Res; 2016; 2016():7047238. PubMed ID: 27525285
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory cytokines in diabetic nephropathy.
Donate-Correa J; Martín-Núñez E; Muros-de-Fuentes M; Mora-Fernández C; Navarro-González JF
J Diabetes Res; 2015; 2015():948417. PubMed ID: 25785280
[TBL] [Abstract][Full Text] [Related]
9. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.
Osawa T; Kato Y
Ann N Y Acad Sci; 2005 Jun; 1043():440-51. PubMed ID: 16037265
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
[TBL] [Abstract][Full Text] [Related]
11. The Role of Dietary Antioxidants on Oxidative Stress in Diabetic Nephropathy.
Gerardo Yanowsky-Escatell F; Andrade-Sierra J; Pazarín-Villaseñor L; Santana-Arciniega C; De Jesús Torres-Vázquez E; Samuel Chávez-Iñiguez J; Ángel Zambrano-Velarde M; Martín Preciado-Figueroa F
Iran J Kidney Dis; 2020 Mar; 14(2):81-94. PubMed ID: 32165592
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress in diabetic nephropathy.
Kashihara N; Haruna Y; Kondeti VK; Kanwar YS
Curr Med Chem; 2010; 17(34):4256-69. PubMed ID: 20939814
[TBL] [Abstract][Full Text] [Related]
13. CXCL16 deficiency attenuates diabetic nephropathy through decreasing oxidative stress and inflammation.
Ye Y; Chen Q; Li J; Jin L; Zheng J; Li X; Lin Z; Gong F
Biochem Biophys Res Commun; 2017 Sep; 491(3):848-854. PubMed ID: 28478039
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia to nephropathy via transforming growth factor beta.
Garud MS; Kulkarni YA
Curr Diabetes Rev; 2014 May; 10(3):182-9. PubMed ID: 24919657
[TBL] [Abstract][Full Text] [Related]
15. Cytokines in diabetic nephropathy.
Wu CC; Sytwu HK; Lin YF
Adv Clin Chem; 2012; 56():55-74. PubMed ID: 22397028
[TBL] [Abstract][Full Text] [Related]
16. Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis.
Maeda S; Matsui T; Takeuchi M; Yamagishi S
Diabetes Metab Res Rev; 2013 Jul; 29(5):406-12. PubMed ID: 23508966
[TBL] [Abstract][Full Text] [Related]
17. The role of IL-20 in chronic kidney disease and diabetic nephropathy: Pathogenic and therapeutic implications.
Chang MS; Hsu YH
J Leukoc Biol; 2018 Nov; 104(5):919-923. PubMed ID: 29999545
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycosylated end products-mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress.
Gupta A; Tripathi AK; Tripathi RL; Madhu SV; Banerjee BD
Indian J Biochem Biophys; 2007 Oct; 44(5):373-8. PubMed ID: 18341213
[TBL] [Abstract][Full Text] [Related]
19. [Advanced glycation end products (AGEs), free radicals and diabetes].
Gillery P
J Soc Biol; 2001; 195(4):387-90. PubMed ID: 11938555
[TBL] [Abstract][Full Text] [Related]
20. Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy: Promises and Challenges.
ElGamal H; Munusamy S
Protein Pept Lett; 2017; 24(1):71-77. PubMed ID: 27894247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
